Pfizer (PFE) Curent Deferred Tax Liability (2009)

Pfizer's (PFE) quarterly Curent Deferred Tax Liability came in at $1.8 billion in Q3 2009.

Analysis

Pfizer (PFE) Curent Deferred Tax Liability (2009) Analysis & Trends

Pfizer (PFE) has reported Curent Deferred Tax Liability for 1 consecutive years, with $1.8 billion the latest figure, recorded in Q3 2009.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Curent Deferred Tax Liability (Qtr)
1	Johnson & Johnson	650.65 Bn	629.89 Bn	17.26 Bn	-
2	AbbVie	466.34 Bn	459.82 Bn	12.70 Bn	-
3	Merck	362.11 Bn	355.02 Bn	12.21 Bn	-
4	Novartis Ag	267.81 Bn	260.52 Bn	11.24 Bn	-
5	Pfizer	157.31 Bn	145.91 Bn	10.94 Bn	-
6	Bristol Myers Squibb	128.75 Bn	117.69 Bn	9.25 Bn	-
7	Sanofi	51.80 Bn	44.84 Bn	10.79 Bn	-
8	Revolution Medicines	40.91 Bn	40.91 Bn	-	-
9	BeOne Medicines	39.65 Bn	34.55 Bn	1.53 Bn	-
10	Incyte	25.18 Bn	20.65 Bn	1.57 Bn	-

Historic Data

Download Data

Date	Value
Sep 27, 2009	1.82 Bn